Latest California Healthline Stories
Scope Maker Olympus Hit With $6.6 Million Verdict In Superbug Outbreak Case
In the first case of its kind in the U.S., the company was ordered to pay damages to the hospital where a patient died of an infection linked to a contaminated scope. But jurors also found the hospital negligent, and it was ordered to pay the patients’ family $1 million.
Jump-Starting Hard Conversations As The End Nears
An end-of life-planning website can encourage patients to tackle that difficult topic before they become too ill to communicate, according to a new study. But they may be more likely to make concrete plans with help from a doctor or social worker.
Over-The-Counter Devices Hold Their Own Against Costly Hearing Aids
In a head-to-head comparison, several of the cheaper devices performed nearly as well as the expensive hearing aids. The study lends credence to lawmakers’ efforts to get the FDA to set standards for the “personal sound amplification products.”
Follow The Money: Drugmakers Deploy Political Cash As Prices And Anger Mount
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
California Valley Fever Cases Highest On Record
Nearly 5,400 cases of the soil-borne fungal disease were reported in 2016, the largest number since the state began tracking the illness in 1995, according to public health officials.
Senate Parliamentarian Upends GOP Hopes For Health Bill
The parliamentarian finds that provisions of the bill cannot go forward with a simple majority vote.
Trump Plan Might Cut Expenses For Some Insured Patients With Chronic Needs
High-deductible health insurance plans linked to a health savings account cannot cover some care and drug expenses for chronic health conditions until the patient has met a deductible.
These Preventive Measures Might Help Delay Dementia Or Cognitive Decline
Recent research shows that controlling blood pressure, exercising and cognitive training around middle age could help prevent cognitive decline or Alzheimer’s disease.
Latinos Left Out Of Clinical Trials … And Possible Cures
Fewer than 8 percent of enrollees in medical studies are Hispanic. Those who don’t participate have less access to cutting-edge treatments, and researchers have less data on how a drug works within the Hispanic population.
Latinos quedan fuera de estudios médicos… y posibles curas
Los ensayos clínicos permiten que miles de pacientes reciban drogas y terapias de avanzada. Pero los hispanos muchas veces no logran acceder a esta opción, por múltiples disparidades.